Immunologic Paralysis
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Esmolol in Sepsis Management:Evaluating Immunomodulatory Effects and Impact on Patient Outcomes (NCT06390748) | Lin Chen | 2021-01-01 |
| Immune Homeostasis in Sepsis and Septic Shock (NCT04448951) | Charles University, Czech Republic | 2020-09-01 |
Track Immunologic Paralysis automatically
Every clearance here is in the API, with alerts when new ones post.